{"id":447912,"title":"Consultation on the Prescription Drug List: Naloxone - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T15:35:19.397000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-prescription-drug-list-naloxone.html?wbdisable=false","snippet":"Consultation on the Prescription Drug List: Naloxone The purpose of this Notice of Consultation is to provide an opportunity to comment on the proposal to revise the listing for Naloxone on the Prescription Drug List (PDL) to allow the non-prescription use of Naloxone. A…","rawSnapshotUrl":"/api/snapshots/raw/447912","browseUrl":"https://replay.healtharchive.ca/job-6/20260103153519/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-prescription-drug-list-naloxone.html?wbdisable=false#ha_snapshot=447912","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}